TCM (4169) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 泰宗

TCM (4169) reported revenue of NT$62 million for Oct 2026, +10.2% year on year and -0.6% from the previous month. Revenue for Jan–Oct 2026 was NT$602.3 million (+6.3% year on year).

In Oct 2026, it ranked No. 94 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$47.4 million24/10Nov 2024 NT$54.9 millionDec 2024 NT$69.5 millionJan 2025 NT$43.1 millionFeb 2025 NT$55.6 million25/02Mar 2025 NT$56.6 millionApr 2025 NT$51.2 millionMay 2025 NT$69 millionJun 2025 NT$62.3 million25/06Jul 2025 NT$57.9 millionAug 2025 NT$51.1 millionSep 2025 NT$63.7 millionOct 2025 NT$56.3 million25/10Nov 2025 NT$63.4 millionDec 2025 NT$55.3 millionJan 2026 NT$65.3 millionFeb 2026 NT$45.8 million26/02Mar 2026 NT$61.8 millionApr 2026 NT$59.1 millionMay 2026 NT$57.2 millionJun 2026 NT$64.8 million26/06Jul 2026 NT$61.8 millionAug 2026 NT$62.2 millionSep 2026 NT$62.4 millionOct 2026 NT$62 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$62 million+10.2%-0.6%
Sep 2026NT$62.4 million-2.1%+0.3%
Aug 2026NT$62.2 million+21.8%+0.7%
Jul 2026NT$61.8 million+6.7%-4.7%
Jun 2026NT$64.8 million+4.0%+13.3%
May 2026NT$57.2 million-17.2%-3.3%
Apr 2026NT$59.1 million+15.4%-4.3%
Mar 2026NT$61.8 million+9.1%+34.7%
Feb 2026NT$45.8 million-17.6%-29.7%
Jan 2026NT$65.3 million+51.6%+18.0%
Dec 2025NT$55.3 million-20.4%-12.7%
Nov 2025NT$63.4 million+15.4%+12.6%
Oct 2025NT$56.3 million+18.6%-11.7%
Sep 2025NT$63.7 million+28.2%+24.8%
Aug 2025NT$51.1 million-16.9%-11.8%
Jul 2025NT$57.9 million+8.1%-7.0%
Jun 2025NT$62.3 million+29.0%-9.7%
May 2025NT$69 million+22.1%+34.7%
Apr 2025NT$51.2 million-16.3%-9.5%
Mar 2025NT$56.6 million+12.6%+1.8%
Feb 2025NT$55.6 million+35.5%+29.2%
Jan 2025NT$43.1 million-40.7%-38.1%
Dec 2024NT$69.5 million-11.3%+26.6%
Nov 2024NT$54.9 million-44.4%+15.8%
Oct 2024NT$47.4 million-46.1%-4.5%

Jan–Oct 2026 cumulative: NT$602.3 million (+6.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: TCM vs PEC / TCM vs Lotus Pharm / TCM vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16